SK

Surinder Kaur Grewal

Active Director Director DIN 07732160
DIN 07732160 First appointment Feb 2017 Primary industry Agriculture
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Surinder Kaur Grewal

Data last updated:

Surinder Kaur Grewal is a Director at Noor Biotech Private Limited (since 2017). The company operates in Agriculture.

DIN 07732160
Primary Designation Director
Industry Agriculture
First Appointment 15 Feb 2017
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Noor Biotech Private Limited U01400HR2015PTC057528
Director15 Feb 20172015Active

Board colleagues of Surinder Kaur Grewal

NameDINCompanyDesignation
Ekta Grewal07634824Noor Biotech Private LimitedDirector
Thakur Onkar Singh06867498Noor Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Noor Biotech Private Limited
Premium access

Shareholding and investment profile for Surinder Kaur Grewal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surinder Kaur Grewal

Surinder Kaur Grewal currently holds 1 directorship: Noor Biotech Private Limited (Director, since 15 Feb 2017).

Surinder Kaur Grewal was first appointed on 15 Feb 2017 as Director at Noor Biotech Private Limited.

The current boards of Surinder Kaur Grewal's companies include Ekta Grewal (Noor Biotech Private Limited), Thakur Onkar Singh (Noor Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available